miR-17-92 plays an oncogenic role and conveys chemo-resistance to cisplatin in human prostate cancer cells
- 15 February 2016
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 48 (4) , 1737-1748
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 57 references indexed in Scilit:
- The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and diseaseCell Death & Differentiation, 2013
- Diet, MicroRNAs and Prostate CancerPharmaceutical Research, 2010
- Tumorigenicity of the miR-17-92 cluster distilled: Figure 1.Genes & Development, 2010
- Genetic dissection of the miR-17∼92 cluster of microRNAs in Myc-induced B-cell lymphomasGenes & Development, 2009
- The Role of microRNA-221 and microRNA-222 in Androgen-Independent Prostate Cancer Cell LinesCancer Research, 2009
- MicroRNA Expression Profiling in Prostate CancerCancer Research, 2007
- A microRNA expression signature of human solid tumors defines cancer gene targetsProceedings of the National Academy of Sciences, 2006
- MicroRNA expression profiles classify human cancersNature, 2005
- A microRNA polycistron as a potential human oncogeneNature, 2005
- Identification and Characterization of a Novel Gene, C13orf25 , as a Target for 13q31-q32 Amplification in Malignant LymphomaCancer Research, 2004